Brief: Sequent Scientific says Alivira gets US FDA approval for Visakhapatnam facility
May 2 (Reuters) - Sequent Scientific Ltd SEQU.NS
* Says Alivira has received US FDA approval for its animal
health API facility at Visakhapatnam, Andhra Pradesh.
Source text - (http://bit.ly/2qsJE5o)
Further company coverage: SEQU.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Says Bioforlife Italia Acquisition Expected To Complete Within Two Months From Sept 8
Brief: Viyash Scientific Ltd June-Quarter Consol Net Profit 658.7 Million Rupees
Brief: Viyash Scientific's Subsidiary To Buy 100% Of Bioforlife Italia
Brief: Viyash Scientific March-Quarter Consol Net Profit 521.1 Million Rupees
Brief: Viyash Scientific Partners With Boehringer Ingelheim In India